Search

Your search keyword '"Knol EF"' showing total 287 results

Search Constraints

Start Over You searched for: Author "Knol EF" Remove constraint Author: "Knol EF" Database MEDLINE Remove constraint Database: MEDLINE
287 results on '"Knol EF"'

Search Results

1. EAACI guidelines on the management of IgE-mediated food allergy.

2. IgE versus IgG and IgA: Differential roles of allergen-specific antibodies in sensitization, tolerization, and treatment of allergies.

3. Neuroinflammatory markers at school age in preterm born children with neurodevelopmental impairments.

4. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

7. Large scale sequence-based screen for recessive variants allows for identification and monitoring of rare deleterious variants in pigs.

8. Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin.

9. The impact of Box-Cox transformation on phenotypic and genomic characteristics of litter size variability in Landrace pigs.

10. Identification of the genetic basis of sow pelvic organ prolapse.

11. Preimplantation Genetic Testing for Aneuploidy (PGT-A) Reveals High Levels of Chromosomal Errors in In Vivo-Derived Pig Embryos, with an Increased Incidence When Produced In Vitro.

12. The genetic basis of swine inflammation and necrosis syndrome and its genetic association with post-weaning skin damage and production traits.

13. Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment.

14. Genetic aspects of piglet survival and related traits: a review.

15. Measurement of IgE to hazelnut allergen components cannot replace hazelnut challenge in Dutch adults.

16. A multi-suckling system combined with an enriched housing environment during the growing period promotes resilience to various challenges in pigs.

17. Effects of a Multi-Suckling System Combined With Enriched Housing Post-Weaning on Response and Cognitive Resilience to Isolation.

18. Impact of Enrichment and Repeated Mixing on Resilience in Pigs.

19. Evaluation of the phenotypic and genomic background of variability based on litter size of Large White pigs.

20. Allergy: Type I, II, III, and IV.

21. Relationship between indirect genetic effects for growth, environmental enrichment, coping style and sex with the serum metabolome profile of pigs.

22. COVID-19 pandemic and allergen immunotherapy-an EAACI survey.

23. Seeking diagnostic and prognostic biomarkers for childhood bacterial pneumonia in sub-Saharan Africa: study protocol for an observational study.

24. Investigating pig survival in different production phases using genomic models.

25. Systemic and local evidence for complement involvement in chronic spontaneous urticaria.

26. Applying an association weight matrix in weighted genomic prediction of boar taint compounds.

27. Accurate Prediction of Peanut Allergy in One-Third of Adults Using a Validated Ara h 2 Cutoff.

28. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).

29. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.

31. Unraveling the actual background of second litter syndrome in pigs: based on Large White data.

32. Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers.

33. Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases-An EAACI position paper of the Task Force on Immunopharmacology (TIPCO).

34. Influence of the metabolic state during lactation on milk production in modern sows.

35. Estimation of litter size variability phenotypes in Large White sows.

36. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement.

37. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).

38. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA) A , Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI) B , Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA) C , Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI) D , Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI) E , Österreichische Gesellschaft für Pneumologie (ÖGP) F in co-operation with the German, Austrian, and Swiss ARIA groups G , and the European Academy of Allergy and Clinical Immunology (EAACI) H .

40. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.

41. Quantifying Individual Response to PRRSV Using Dynamic Indicators of Resilience Based on Activity.

42. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.

43. Basophil Stimulation and Signaling Pathways.

44. Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry.

45. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.

46. Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment.

47. Management of Cow's Milk Allergy from an Immunological Perspective: What Are the Options?

49. Genetic correlations between growth performance and carcass traits of purebred and crossbred pigs raised in tropical and temperate climates1.

50. [AR101: therapy for peanut allergy finally in view?]

Catalog

Books, media, physical & digital resources